Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Total Current Liabilities (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Total Current Liabilities for 8 consecutive years, with $15.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Total Current Liabilities rose 25.15% to $15.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $15.0 million, a 25.15% increase, with the full-year FY2024 number at $15.0 million, down 70.03% from a year prior.
  • Total Current Liabilities was $15.0 million for Q3 2025 at Precision Biosciences, up from $13.6 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $63.8 million in Q1 2021 to a low of $12.0 million in Q3 2024.
  • A 5-year average of $37.6 million and a median of $36.3 million in 2021 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: surged 168.54% in 2021, then crashed 76.33% in 2024.
  • Precision Biosciences' Total Current Liabilities stood at $36.0 million in 2021, then soared by 65.83% to $59.7 million in 2022, then decreased by 16.22% to $50.0 million in 2023, then plummeted by 70.03% to $15.0 million in 2024, then grew by 0.11% to $15.0 million in 2025.
  • Per Business Quant, the three most recent readings for DTIL's Total Current Liabilities are $15.0 million (Q3 2025), $13.6 million (Q2 2025), and $12.4 million (Q1 2025).